Megadose drug combination (Cell Source)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMegadose drug combination (Cell Source)
Drug Alias NameN/A
ClassificationBiologics > BiosimilarCell and gene therapy > Cell therapy
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsBone marrow transplant rejection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCell SourceThe University Of Parma
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of ParmaCell Source
Inactive CompaniesN/A
Active IndicationsBone marrow transplant rejection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A